SW
RXST icon

SVB Wealth’s RxSight RXST Stock Holding History

SVB Wealth’s Portfolio RXST Stock Details RXST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-76,816
Closed -$1.94M – 1402
2025
Q1 		$1.94M Hold
76,816
– – 0.08% 117
2024
Q4 		$2.64M Buy
+76,816
New +$3.46M 0.05% 200
2023
Q4 		– Sell
-8,397
Closed -$234K – 934
2023
Q3 		$234K Hold
8,397
– – 0.01% 696
2023
Q2 		$242K Sell
8,397
-13,633
-62% -$303K ﹤0.01% 754
2023
Q1 		$367K Hold
22,030
– – 0.01% 648
2022
Q4 		$279K Buy
22,030
+11,015
+100% +$134K ﹤0.01% 772
2022
Q3 		$132K Buy
+11,015
New +$151K ﹤0.01% 893
2022
Q2 		– Sell
-20,303
Closed -$251K – 831
2022
Q1 		$251K Buy
+20,303
New +$244K ﹤0.01% 629

Other funds holding RXST

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
NSGL
No Street GP LP San Francisco, California $1.5B AUM 34.53% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SVB Wealth's RXST Position: Q2 2025 in Review

SVB Wealth sold out of RxSight (RXST) in Q2 2025, closing a stake of 76,816 shares — an estimated $1.94M sold.

SVB Wealth first reported a position in RXST in Q1 2022 and held it in 8 quarters. The position peaked at $2.64M in Q4 2024. 174 funds tracked by Wall St. Rank hold RXST as of Q2 2025.

  • SVB Wealth reported no remaining RxSight position as of Q2 2025 after selling out during the quarter.
  • SVB Wealth sold 76,816 RxSight shares in Q2 2025, an estimated $1.94M.
  • SVB Wealth first reported a position in RxSight in Q1 2022 and held it in 8 quarters.
  • SVB Wealth's RxSight position peaked at $2.64M in Q4 2024.
  • 174 funds tracked by Wall St. Rank held RxSight as of Q2 2025.

Based on SVB Wealth's 13F filing for Q2 2025, filed 14 Aug 2025.